Latest News about GSK
Recent news which mentions GSK
   GSK Settles Another California Lawsuit On Heartburn Drug Zantac Causing Cancer, Second Within A Month
   
  
  
  February 29, 2024
  From Benzinga
 
   11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
   
  
  
  February 28, 2024
  From Benzinga
 
   GSK's Gepotidacin Oral Antibiotic Non-Inferior To Commonly Used Muscle-Injected Antibiotic Combo For Sexually Transmitted Infection
   
  
  
  February 26, 2024
  From Benzinga
 
   3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
   
  
  
  February 22, 2024
  From InvestorPlace
 
   Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
   
  
  
  February 21, 2024
  From Benzinga
 
   3 Low-Priced Dividend Stocks With Solid Fundamentals & Growth
   
  
  
  February 21, 2024
  From InvestorPlace
 
   Why Is Moderna Stock Trading Lower Today?
   
  
  
  February 09, 2024
  From Benzinga
 
   Jim Cramer Expects Drugmaker Stock To Go 'Even Higher,' As For Kroger: 'What The Heck Is Going On?'
   
  
  
  February 06, 2024
  From Benzinga
 
   The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
   
  
  
  February 06, 2024
  From InvestorPlace
 
   Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
   
  
  
  February 02, 2024
  From Benzinga
 
   Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option
   
  
  
  February 02, 2024
  From Benzinga
 
   What's Going On With GSK Stock Today?
   
  
  
  February 01, 2024
  From Benzinga
 
   GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine
   
  
  
  January 31, 2024
  From Benzinga
 
   Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
   
  
  
  January 31, 2024
  From Benzinga
 
   Earnings Scheduled For January 31, 2024
   
  
  
  January 31, 2024
  From Benzinga
 
   Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
   
  
  
  January 30, 2024
  From Benzinga
 
   Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
   
  
  
  January 29, 2024
  From Benzinga
 
   A Look Into GSK Inc's Price Over Earnings
   
  
  
  January 26, 2024
  From Benzinga
 
   GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
   
  
  
  January 17, 2024
  From Benzinga
 
   Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles
   
  
  
  January 09, 2024
  From Benzinga
 From Benzinga
 
   Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada
   
  
  
  January 05, 2024
  From Benzinga
 
   Why Biopharmaceutical Player CureVac Shares Are Rising Today
   
  
  
  January 05, 2024
  From Benzinga
 
   Sleeper Hits: 3 Unexpected Stocks Poised for a Breakout in 2024
   
  
  
  January 05, 2024
  From InvestorPlace
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
